Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04754425
Title Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer
Recruitment Not yet recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

prostate small cell carcinoma

prostate adenocarcinoma

Therapies

Erdafitinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.